Xacduro-Sulbactam And Durlobactam
Xacduro is an IV antibiotic used for serious lung infections caused by resistant Acinetobacter bacteria. It combines two medicines to fight tough infections effectively.
Paxlovid-Nirmatrelvir And Ritonavir
Paxlovid is an oral treatment for mild to moderate COVID-19 in high-risk patients. It stops the virus from multiplying and helps prevent severe illness when taken early.
Posluma-Flotufolastat F 18
Posluma is a PSMA-targeted PET imaging agent used in prostate cancer. It helps doctors detect and locate primary and metastatic prostate tumors more accurately using a novel radiohybrid compound.
Inpefa-Sotagliflozin
Inpefa is a once-daily oral tablet for adults with heart failure, with or without type 2 diabetes or kidney disease. It reduces the risk of cardiovascular death, hospitalization, or urgent heart failure visits.
Leqembi-Lecanemab-Irmb
Leqembi is a prescription medicine for early-stage Alzheimer’s disease. It’s a monoclonal antibody that helps reduce amyloid plaques in the brain and is the first treatment of its kind approved in the European Union.
Joenja-Leniolisib
Joenja is the first FDA‑approved oral selective PI3Kδ inhibitor for activated phosphoinositide 3‑kinase delta (PI3Kδ) syndrome (APDS). It is administered to patients aged 12 years and older, targeting the underlying immune signaling defect in APDS to address both immunodeficiency and immune dysregulation.
Zynyz-Retifanlimab-Dlwr
Zynyz is the first PD‑1 inhibitor approved by the FDA for adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal. It is now available both as monotherapy and in combination with platinum‑based chemotherapy, and is also approved for metastatic Merkel cell carcinoma; it enhances T‑cell activity to target and […]
Rezzayo-Rezafungin Acetate
Rezzayo is the first new echinocandin antifungal approved by the FDA in over 15 years for adults with limited or no alternative options for treating candidemia and invasive candidiasis. It works by inhibiting fungal β-glucan synthase, thereby disrupting cell wall synthesis, and simplifying care with once-weekly intravenous dosing.
Brenzavvy-Bexagliflozin
Brenzavvy is an SGLT2 inhibitor that helps lower your average blood sugar level over 90 to 120 days. It’s FDA-approved to be used alongside diet and exercise to manage blood sugar in adults with type 2 diabetes.
Jaypirca-Pirtobrutinib
Jaypirca is a non-covalent BTK inhibitor used to treat adults with relapsed or refractory mantle cell lymphoma and chronic lymphocytic leukemia after prior treatments. It’s taken orally once daily.
